Management of the High-Risk Patient/Hereditary Predisposition
Implementation of a High-Risk Breast Program
Pre-conference course highlight
Dawn Mussallem, MD; Allison Kurian, MD, MSc; Lora Barke, MD; Dominique Smith, RT (M), BIN
Stephanie Graff, MD; Dagny Oliver, NP; Andrea Kaster, MD
Developing and implementing a High-Risk Breast Program is an exciting and complex process in which there is no "one size fits all" approach. A true comprehensive program requires the dedication and investment of various stakeholders with different and often divergent perspectives, values and goals, which can make implementation a challenge. Additionally, the lack of robust data about clinical and financial outcomes can make development of the business case difficult. Administrators and clinicians in the community setting are often grappling with which resources and investments are needed, along with understanding how to pull everything together to launch a sustainable, comprehensive program.
Management of the high-risk patient entails a multimodal and personalized approach. This high-risk session will include state of the art presentations on the identification of high risk patients, risk model utilization, the role of enhanced surveillance for early detection of breast cancer, lifestyle modification and risk reducing medications. With the advent of newer multi-gene panel tests, experts will review the importance of addressing patient desires, understanding of results and advisable thresholds for consideration of testing. A panel of breast health specialists will present case studies in the management of high-risk patients.
The afternoon sessions focus primarily on developing, justifying and operationalizing a top-notch High-Risk Breast Program, and the key business considerations for planning, developing and implementing, along the care continuum. It will be applicable to administrators and clinical providers, including nurse navigators, nurse practitioners, physicians, physician assistants and genetic counselors.
Breakfast Symposia with Myriad
Defining the High-Risk Clinic and Identification of the High-Risk Patient Holly Pederson, MD
Risk Assessment Models- Pros and Cons and Using Models for Personalized Risk Assessment Dawn Mussallem, MD
Should Everyone Have Genetic Testing? Allison Kurian, MD, MSc
What’s New in Surveillance Imaging Options for High Risk Patients? Lora Barke, MD
Lifestyle Modification and Pharmacologic Options for Breast Cancer Risk Reduction Sandhya Pruthi, MD
CASES: Panel Discussion: Management of the High-Risk Patient Dawn Mussallem, MD Moderating with Holly Pederson, MD; Alison. Kurian, MD, MSc; Lora Barke, MD; Sandhya Pruthi, MD
Lunch on Your Own
Designing the High-Risk Breast Program Teresa Heckel, MBA, FABC, FNCBC & Mary Freivogel, MS, CGC
Critical Role of the Breast Imaging Navigator Dominique Smith, RT (M), BIN
Business Considerations in Genetic Counseling Mary Freivogel, MS, CGC
Communications & Collaborations: Bridging Relationships with Referring Physicians Stephanie Graff, MD
Role of the High-Risk Advanced Practice Nurse Provider in High Risk Medical Management Dagny Oliver, NP
Building the Business Case for a High-Risk Breast Program Teresa Heckel, MBA, FABC, FNCBC
Highlighting High Risk Breast Program Success Factors in the Community Setting Mary Freivogel, MS, CGC Moderating with Andrea Kaster, MD; Dominique Smith, RT (M), BIN; Dagny Oliver, NP; Lora Barke, MD
Pre-Conference Course Ends at 4:30 PM
Take advantage of early bird pricing valid through March 6, 2020
Cancellation Policy: NCBC will provide a full conference refund less a $50.00 processing fee until January 31, 2020. No Conference refunds will be given after February 1, 2020. No Refunds on Certifications once the Study Materials have been sent.
Pre Conference Course Registration
No products found
Interested in attending the 3 day 30th Annual Interdisciplinary Breast Center Conference?
Saturday, April 04 - Monday, April 06, 2020
No products found